U.S. Pharmaceutical Sterility Testing Market to 2025 by Type (In-house, Outsourced), Test Type (Bacterial Endotoxin, Sterility), End Use, Sample and Segment Forecasts - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 7, 2018--The “U.S. Pharmaceutical Sterility Testing Market Size, Share & Trends Analysis Report By Type (In-house, Outsourced), By Test Type (Bacterial Endotoxin, Sterility), By End Use, By Sample, And Segment Forecasts, 2018 - 2025” report has been added to ResearchAndMarkets.com’s offering.
The U.S. pharmaceutical sterility testing market size is expected to reach USD 713.6 million by 2025 and is anticipated to expand at a CAGR of 11.3% over the forecast period.
Supportive government investment in healthcare industry, increasing R&D activities, and drug launches are the key factors driving market growth.
The government is keen on bringing down healthcare costs which is anticipated to encourage the U.S. Food and Drug Administration (FDA) to promote fast approvals of generic pharmaceuticals. Faster approvals drive the need for newer sterility testing methods. This is anticipated to encourage market participants to spend more on sterility solutions and in turn, expand the market. With increasing demand for drugs, companies are launching newer drugs with different routes of administration, dosage, and indication. These launches require thorough sterility testing and thus, are anticipated to drive market growth.
On the basis of type, the U.S. pharmaceutical sterility testing market is segmented into in-house and outsourcing. Most market players prefer outsourcing sterility testing services, as it is economically viable. Companies shortlist and select outsourcing firms based on their experience, expertise, and quality of service. Hence, it is difficult for new players to enter into this area.
Companies active in the U.S. pharmaceutical sterility testing market are Charles River Laboratories, Pace Analytical Series LLC, DynaLabs, Infinity, Boston Analytical, and others. Market players employ various growth strategies such as mergers, capacity expansion, and venturing into new regions.
Key Topics Covered:
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 U.S. Pharmaceutical Sterility Testing Market: Variables, Trends & Scope
Chapter 4 U.S. Pharmaceutical Sterility Testing Market: Type Estimates & Trend Analysis
Chapter 5 U.S. Pharmaceutical Sterility Testing Market: Test Type Estimates & Trend Analysis
Chapter 6 U.S. Pharmaceutical Sterility Testing Market: End-use Estimates & Trend Analysis
Chapter 7 U.S. Pharmaceutical Sterility Testing Market: Sample Estimates & Trend Analysis
Chapter 8 Regional Estimates & Trend Analysis, by Type, Test type, Sample, End-use
Chapter 9 Competitive LandscapePacific Biolabs STERIS Corporation. Boston Analytical Gibraltar Laboratories Infinity Laboratories Dynalabs SGS SA Toxikon, Inc. Pace Analytical Services LLC Charles River Laboratories International, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/577sc8/u_s?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181107005527/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Pharmaceutical Manufacturing
KEYWORD: UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 11/07/2018 08:55 AM/DISC: 11/07/2018 09:34 AM